510(k) K132515
K132515 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "LIAISON N-TACT PTH GEN II, CONTROL SET, CALIBRATION VERIFIERS". The FDA issued a decision of Substantially Equivalent on November 8, 2013. The device falls under product code CEW (Radioimmunoassay, Parathyroid Hormone), a Class II device regulated under 21 CFR 862.1545. DiaSorin, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 8, 2013
- Date Received
- August 12, 2013
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Parathyroid Hormone
- Device Class
- Class II
- Regulation Number
- 862.1545
- Review Panel
- CH
- Submission Type